HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 277, Issue 21, 18598-18604, May 24, 2002

This Article Abstract Full Text (PDF) All Versions of this Article: 277/21/18598    most recent M201868200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Laroche-Joubert, N. Articles by Doucet, A. Search for Related Content PubMed PubMed Citation Articles by Laroche-Joubert, N. Articles by Doucet, A. Social Bookmarking                      What's this?

Protein Kinase A-independent Activation of ERK and H,K-ATPase by cAMP in Native Kidney Cells

ROLE OF Epac I^*

Nicolas Laroche-Joubert, Sophie Marsy, Stéphanie Michelet, Martine Imbert-Teboul, and Alain Doucet

From the Laboratoire de Biologie Intégrée des Cellules Rénales, Service de Biologie Cellulaire, Commissariat á l'Energie Atomique, Saclay, Unité de Recherche Associée 1859, CNRS, 91191 Gif-sur-Yvette Cedex, France

Received for publication, February 25, 2002

	ABSTRACT

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

This study aimed at determining the signaling pathways underlying calcitonin- and isoproterenol-induced stimulation of H,K-ATPase in rat renal collecting duct. H,K-ATPase activity was determined in microdissected collecting ducts preincubated with or without either specific inhibitors or antibodies directed against intracellular signaling proteins. Transient cell membrane permeabilization with streptolysin-O allowed intracellular access of antibodies. The stimulation of H,K-ATPase by calcitonin and isoproterenol was mimicked by cAMP analogues and was abolished by adenylyl cyclase inhibition. Protein kinase A inhibition abolished isoproterenol but not calcitonin effect on H,K-ATPase. Calcitonin increased the phosphorylation of extracellular signal-regulated kinase (ERK) in a protein kinase A-independent manner, and the inhibition of the ERK phosphorylation prevented the stimulation of H,K-ATPase by calcitonin. Antibodies directed against either the cAMP-activated guanine-nucleotide exchange factor Epac I, the monomeric G protein Rap-1 or the kinase Raf-B, curtailed the stimulation of H,K-ATPase by calcitonin, whereas antibodies against the related monomeric G protein Ras or kinase Raf-1 had no effect. In conclusion, calcitonin stimulates H,K-ATPase through a cAMP/Epac I/Rap-1/Raf-B/ERK cascade.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

The rat kidney cortical collecting duct (CCD)¹ consists of three intermingled cell types expressing specific hormone receptors positively coupled to adenylyl cyclase via G proteins (1): principal cells with vasopressin V₂ receptors, -intercalated (I) cells with calcitonin receptors, and -intercalated (I) cells with -adrenergic receptors (1). Although it is difficult to physically separate pure populations of these different cell types, one can determine the cellular origin of cAMP-mediated responses on the basis of this hormone selectivity. Using this approach, we have previously reported that in rat CCD, the H,K-ATPase is present in both I and I cells in which it is stimulated by salmon calcitonin (Sct) and isoproterenol (Iso), respectively (2). The stimulation of H,K-ATPase, along with that of H-ATPase reported previously (3), probably participates in the regulation of proton transport by these two hormones (3, 4).

The signaling mechanisms underlying the regulation of H,K-ATPase in I and I cells remain unclear for two reasons. Firstly, besides activating the Gs/adenylyl cyclase/cAMP/protein kinase A (PKA) pathway, calcitonin and isoproterenol also increase intracellular Ca²⁺ concentration ([Ca²⁺]_i) in rat CCD (5-7). Secondly, several cAMP-binding proteins other than PKA have now been described: the cAMP receptor of Dictyostelium discoideum, which participates in the regulation of the development of this unicellular eukaryote (8), S-adenosyl homocysteine hydrolase, which participates in the regulation of protein methylation (9), cyclic nucleotide-gated channels involved in transduction of olfactory and visual signals (10, 11), and cAMP-activated guanine-nucleotide exchange factors (GEF) (Epac I or cAMP-GEF I and CNrasGEF), which activate specifically the monomeric G proteins of the Ras family, Rap-1 and Ras, respectively (12-14). Thus, depending on the nature of cAMP-binding proteins expressed in different cell types and on their supramolecular organization, the effects of cAMP may be mediated by PKA-dependent or independent mechanisms. Interestingly, the kidney is one of the tissues displaying the highest levels of expression of mRNAs encoding Epac I (12, 13) and the cyclic nucleotide-gated channel 3 (15), making possible an important role of these two proteins in the signalization of cAMP actions in kidney cells.

Thus, the aim of this study was to determine the signaling pathways underlying the stimulation of H,K-ATPase activity by Sct and Iso in the rat CCD, in particular the involvement of the cAMP-binding proteins PKA, Epac I, and cyclic nucleotide-gated channels.

	MATERIALS AND METHODS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Animal Preparation and Tubule Microdissection-- Experiments were carried out on male Sprague-Dawley rats anesthetized with sodium pentobarbital (50 mg/kg body weight). Cortical collecting ducts were dissected at 4 °C from collagenase-treated kidneys as described previously (16). After microdissection, the ducts were photographed to determine their length, which served to normalize results. Unless indicated otherwise, microdissection was carried out in a solution containing (in mM) 120 NaCl, 5 KCl, 1 MgSO₄, 4 NaHCO₃, 0.2 NaH₂PO₄, 0.15 Na₂HPO₄, 5 glucose, 0.5 CaCl₂, 0.08 dextran, 2 lactate, 20 Hepes, 4 essential and nonessential amino acids, 0.03 vitamins, and 1 mg/ml bovine serum albumin. The pH was adjusted to 7.4, and osmotic pressure was adjusted to 400 mosmol/kg with mannitol. For RNA extraction, tubule isolation was run under "RNase-free conditions" (17). For Western blotting analysis, antiproteases (1 µg ml¹ leupeptin, 10 µg ml¹ aprotinin, 10 µg ml¹ aminoethylbenzenesulfonyl fluoride, and 10 µg ml¹ antipain) were added to the dissection solution.

Pretreatment with Inhibitors and Hormones-- Microdissected CCDs were preincubated with specific inhibitors of different intermediates of signaling pathways or with their solvent before incubation with hormones. Pools of CCDs dissected from collagenase-treated kidneys (2-4 mm in length) were pretreated with or without the inhibitors at 30 °C for 45-120 min before treatment with hormones (10 min at 37 °C). The hormone treatment was stopped by cooling the samples at 4 °C. H89 dihydrochloride, myristoylated protein kinase A peptide inhibitor 14-22 amide, and bisindolylmaleimide I were from Calbiochem. U0126 (1,4-diamino-2,3-dicyano-1,4-bis-(O-aminophenylmercapto)butadiene) was from Sigma. All inhibitors were prepared from aqueous solutions with the exception of U0126, which was dissolved in dimethyl sulfoxide (Me₂SO). The corresponding control groups contained the same concentration of Me₂SO (<0.1% v/v).

When specific inhibitors were not commercially available, we evaluated the effect of antibodies directed against several signaling proteins. Intracellular entry of antibodies was made possible by transient permeabilization of CCD cells by streptolysin-O (18, 19). For this purpose, pools of CCDs were first preincubated at 37 °C for 8 min and then for 90 min at 4 °C with or without the antibody in a medium containing (in mM) 137 NaCl, 3 KCl, 5 glucose, 20 Pipes, 1 mg/ml bovine serum albumin, and 0.2 IU/ml streptolysin-O (Sigma) at pH 6.8. CCDs were then transferred into the usual dissection medium and incubated with hormones as described above. All antibodies used were from Santa Cruz Biotechnology (Tebu, Le Perray en Yvelines, France): affinity-purified rabbit polyclonal antibody against a peptide mapping at the C terminus of the -catalytic subunit of human PKA (sc-903); affinity-purified goat polyclonal antibodies against a peptide mapping near the C terminus (catalytic domain) or at the N terminus (cAMP-binding domain) of human Epac I (sc-8880 and sc-8879, respectively); affinity-purified rabbit polyclonal antibody against a peptide mapping at the C terminus of human B-Raf (sc-166); rabbit polyclonal IgG against an epitope mapping near the C terminus of human Rap-1A (sc-65); a monoclonal IgG₁ antibody raised against a peptide mapping at the C terminus of Raf-1 p74 of human origin (sc-7267); and an affinity purified rat monoclonal antibody derived by fusion of spleen cells from a rat immunized with Y3Ag 1.2.3. rat myeloma cells (sc-35). Although all of these antibodies were directed against the active portion of the proteins (12, 20, 21), the anti-Ras antibody was the only one with reported inhibitory properties (22).

H,K-ATPase Activity Assay-- H,K-ATPase activity was determined using the radiochemical microassay described previously (23) and adapted for microplate assay. To avoid contamination with Na,K-ATPase, CCDs were rinsed in a cold Na⁺-free solution containing (in mM) 0.8 MgSO₄, 1 MgCl₂, 0.5 CaCl₂, 100 Tris-HCl, 1 mg/ml bovine serum albumin, and mannitol up to 400 mosmol/kg at pH 7.4. After transfer within 0.5 µl of rinsing solution into a 96-well flat bottom plastic microplate, samples were permeabilized by adding 2 µl of hypotonic solution (10 mM Na⁺-free Tris-HCl, pH 7.4, with or without 10⁴ M Sch-28080) to each sample and freezing on dry ice. After thawing and adding 10 µl of assay medium (see composition below), the microplate was incubated at 37 °C for 15 min. The incubation was stopped by cooling and adding 300 µl of an ice-cold suspension of 15% (w/v) activated charcoal. After centrifugation, aliquots of 50 µl of each supernatant were transferred to a 96-well sample microplate for Cerenkov counting (Trilux microbeta 1450, Wallac, Finland).

H,K-ATPase activity was distinguished from other ATP-hydrolyzing activities on the basis of its sensitivity to Sch-28080, a specific inhibitor of the renal H,K-ATPase activities (23). Thus, for each experimental condition, eight samples were divided into two groups, one for measuring total ATPase activity and the other for measuring the ATPase activity in presence of Sch-28080. H,K-ATPase activity was calculated as the difference between these two mean ATPase activities.

The ATPase assay medium contained (in mM) 25 Tris-HCl, 10 MgCl₂, 1 EGTA, 2.5 KCl, 50 Tris-ATP, and 0.2 µCi of [-³²P]ATP with or without 300 µM Sch-28080.

Western Blot Analysis of Phospho-ERKs-- Pools of 30 CCDs dissected in medium supplemented with leupeptin (25 µg ml¹) and aprotinin (25 µg ml¹) were preincubated at 37 °C for 1 h with or without H89 and then at 37 °C for 10 min with or without hormones. Samples were then transferred with 0.5 µl of incubation medium into 14.5 µl of lysis buffer containing (in mM) 100 NaCl, 1.5 MgCl₂, 2 sodium pyrophosphate, 2.5 glycerophosphate, 30 NaF, 1 EGTA, 20 Hepes, 1 µg ml¹ leupeptin, 10 µg ml¹ aprotinin, 10 µg ml¹ aminoethylbenzenesulfonyl fluoride, and 10 µg ml¹ antipain at pH 7.4, vortexed, and kept on ice for 1 h. Cell lysate was centrifuged at 15,000 × g for 10 min, and the supernatant was removed and stored at 80 °C until use.

Supernatants were resuspended (v/v) in 2× Laemmli, heated at 100 °C for 5 min, and analyzed by SDS-PAGE. After electrophoresis on 10% polyacrylamide gels, proteins were electrotransferred on polyvinylidine difluoride membranes (Immobilon-P, Millipore) and incubated for 1 h with anti-phospho-ERK1/2 antibody (dilution 1:2000) in phosphate-buffered saline with 0.1% Tween 20 (v/v) and with 5% (w/v) dried nonfat milk. After washing in Tris-buffered saline-Tween 20, membranes were incubated for 45 min with an anti-rabbit IgG antibody (dilution 1:5000) coupled to horseradish peroxidase (Transduction Laboratories, Lexington, KY) in Tris-buffered saline-Tween 20. The antigen-antibody complexes were detected by chemiluminescence with the SuperSignal substrate method (Pierce) according to the manufacturer's instructions.

In each experiment, the amounts of proteins loaded to each lane of the electrophoresis gel corresponded to the same initial length of isolated CCDs (±5%). The chemiluminescence of each lane was quantified by densitometry (arbitrary units) and expressed in each experiment as the percent of the control lane (no hormone treatment). Results are expressed as means ± S.E. from several animals.

Expression of Epac I and Rap-1 mRNAs-- RNAs were extracted from pools of 20-50 microdissected glomerulus or nephron segments as previously described (17) and summarized below. The pools of tubules were transferred with 10 µl of microdissection solution into 400 µl of denaturing solution (4 M guanidium thiocyanate, 25 mM sodium citrate, pH 7.0, 0.1 M -mercaptoethanol, and 0.5% sarcosyl) and 20 µg of yeast RNA (Amersham Biosciences) used as a carrier. After phenol/chloroform extraction and isopropyl alcohol precipitation, the final RNA pellet was dried under vacuum and dissolved in RNA dilution buffer (10 mM Tris, pH 7.6, 1 mM EDTA, 2 mM dithiothreitol, 40 units/ml RNasin (Promega, Madison, WI)). The yield of this RNA extraction procedure is 90% (17).

Expression of mRNAs encoding Epac I and Rap-1 was evaluated by reverse transcription-PCR using the following specific primers: Epac I sense (5'-CGAGCAGGAACGCAGCACCTACATC-3') and antisense (5'-TCACTTCCCTCACGGAGGCTGTCAC-3'), bases 1429-1453 and 1811-1836 from the initiating ATG, respectively; and Rap-1 sense (5'-GCTCTGACAGTTCAGTTTGTTCAGGGAA-3') and antisense (5'-AACATCTTCCGTGTCCTTAACCGGTAAA-3'), bases 6-34 and 254-282, respectively. Reverse transcription was carried out for 45 min at 45 °C in a final volume of 50 µl in the presence of RNAs from 1 glomerulus or 1 mm of tubular length, of antisense primer (6.25 pmol), dNTP (200 µM), and Moloney murine leukemia virus reverse transcriptase (200 units). PCR was subsequently carried out in the same tube in a final volume of 100 µl after the addition of the sense primer (6.25 pmol), 5 µCi [-³²P]dCTP (6000 Ci mmol¹), and Taq polymerase (1.25 units). Samples were submitted to 30 cycles of three temperature steps: 95 °C for 30 s; 60 °C for 30 s; and 72 °C for 1 min with the exception of the last cycle in which the elongation lasted 10 min. The DNA fragments were separated by electrophoresis on 2% agarose slab gels, which were analyzed by PhosphorImager (Molecular Dynamics) for determining the intensity of the signals.

Measurement of Intracellular Ca²⁺ Concentration-- Intracellular calcium concentration was measured in single microdissected CCDs by using the calcium-sensitive fluorescence probe Fura-2/AM as described previously (5). After 1 h of loading with 10 µM Fura-2/AM in presence or absence of 1 µM PKA inhibitor H89, each CCD was transferred into a superfusion chamber on the stage of an inverted fluorescence microscope (Zeiss IM 35, Oberkochen, Germany). The tubules were superfused (3-4 ml min¹) at 37 °C with a solution containing (in mM) 140 NaCl, 4 KCl, 1 MgCl₂, 0.8 MgSO₄, 0.44 NaH₂PO₄, 0.33 Na₂HPO₄, 1.0 CaCl₂, and 5 glucose with or without 1 µM H89 at pH 7.4. After 5-10-min equilibration period, calcitonin or ATP used as a positive control was added to the superfusate. The tubular portion selected for fluorescence measurements included approximately 30 cells. Double wavelength measurements of Fura-2/AM fluorescence were recorded every 2 s. The calculation of [Ca²⁺]_i was performed as described previously (5).

Statistics-- Results are given as the means ± S.E. from different animals. The data were compared according to either paired or unpaired Student's t test as appropriate or when comparing more than two groups together according to ANOVA test with PLSD Fisher.

	RESULTS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Role of Protein Kinase A in Agonist-induced Stimulation of H,K-ATPase-- Incubation of CCDs with 10 nM Sct or with 1 µM Iso resulted in a mean 4-fold stimulation of H,K-ATPase activity. However, nonstimulated and stimulated H,K-ATPase activities were quite variable between animals, making it necessary to test the different experimental conditions of a same group in the same animals (paired experiments).

Preincubation with 1 µM H89 (Fig. 1A) did not modify basal and Sct-stimulated H,K-ATPase activity but totally blocked the stimulation by Iso. Preincubation with 10 µM myristoylated inhibitory peptide 14-22 amide, another inhibitor of the PKA catalytic subunit, also blocked Iso-induced but not Sct-induced stimulation of H,K-ATPase (Fig. 1B). The effect of H89 and myristoylated inhibitory peptide 14-22 amide were also mimicked by a polyclonal antibody directed against PKA catalytic subunit (Fig. 1C).

View larger version (22K): [in this window] [in a new window]   Fig. 1.   Effect of protein kinase inhibitors on H,K-ATPase. Rat CCDs were preincubated either at 30 °C for 45 min (H89, MPKI) without protein kinase inhibitor (bar C) or with 1 µM H89 (H89) (A), or 10 µM myristoylated inhibitory peptide (MPKI) (B), or at 4 °C for 90 min (C, Anti PKA) in the absence (bar C) or presence of anti-PKA antibody (dilution 1:100) after streptolysin-O permeabilization. Afterward, samples were incubated at 37 °C for 10 min without hormone (solid bars) or with either 10 nM salmon calcitonin (open bars) or 1 µM isoproterenol (hatched bars) before measuring H,K-ATPase activity. N, number of experiments. Statistical comparison between groups was performed by ANOVA with PLSD Fisher. *, p < 0.05; **, p < 0.001 versus control groups (no hormone).

In summary, these results demonstrate that Iso stimulates H,K-ATPase activity through the canonical PKA signaling pathway, whereas the effect of calcitonin is independent of PKA. Therefore, we attempted next to determine the signaling mechanism of calcitonin.

Role of cAMP in Sct-induced Stimulation of H,K-ATPase-- To investigate whether or not cAMP is the second messenger that underlies Sct-induced stimulation of H,K-ATPase in I cells, the requirement for adenylyl cyclase and cAMP was determined by three approaches. Firstly, CCDs were pretreated with 2.5 mM 2',5'-dideoxyadenosine, an inhibitor of adenylyl cyclase. Results show that 2',5'-dideoxyadenosine did not change basal H,K-ATPase activity but abolished its stimulation by Sct (Fig. 2A). This finding demonstrates that adenylyl cyclase activity is essential for the stimulation of H,K-ATPase by Sct. Secondly, to further investigate the role of cAMP in Sct-induced enzyme activation, we determined the effects of the permeant cAMP analogue 8-Br-cAMP (100 µM) and of forskolin (1 µM). Because the results obtained with the two compounds were similar, they were pooled (Fig. 2B). The addition of 8-Br-cAMP or forskolin stimulated H,K-ATPase activity over 8-fold. The fact that this stimulatory factor (×8) equals the sum of those observed in response to Iso (×4) and Sct (×4) suggests that 8-Br-cAMP and forskolin mimick the effects of the two hormones. This observation is further demonstrated by the finding that stimulation by 8-Br-cAMP or forskolin was inhibited by 50% with H89 (as expected from inhibition of -intercalated cells). Finally, Sct-induced stimulation of H,K-ATPase was also mimicked by (R_p)-cAMP (Fig. 2C), a diastereomer of cAMP that inhibits PKA (24).

View larger version (23K): [in this window] [in a new window]   Fig. 2.   Role of cAMP in the stimulation of H,K-ATPase by calcitonin. A, effect of adenylyl cyclase inhibition. After preincubation at 30 °C for 45 min without (bar C) or with 2.5 mM 2',5'-dideoxyadenosine (dD-Ade), CCDs were incubated at 37 °C for 10 min without (solid bars) or with 10 nM salmon calcitonin (open bars). Afterward, H,K-ATPase activity was determined. N, number of experiments. Statistical comparison between groups was performed by ANOVA with PLSD Fisher. **, p < 0.001 versus control values (no calcitonin). B, effect of 8-Br-cAMP and forskolin. After preincubation at 30 °C for 45 min without (bar C) or with 1 µM H89 (H89), CCDs were incubated at 37 °C for 10 min without (solid bar) or with either 100 µM 8-Br-cAMP or 1 µM forskolin (hatched bars). Afterward, H,K-ATPase activity was determined. Results with 8-Br-cAMP (n = 3) and forskolin (n = 3) were identical and therefore were pooled. N, number of experiments. Statistical comparison between groups was performed by ANOVA with PLSD Fisher. *, p < 0.05; **, p < 0.001 versus previous values. C, effect of (Rp)-cAMPs on H,K-ATPase activity. CCDs were incubated at 37 °C for 10 min without (bar C) or with 20 µM (Rp)-cAMPs before measurement of H,K-ATPase activity. Results are the means ± S.E. from N animals. *, p < 0.025 by paired Student's t test.

These findings demonstrate that in I cells, cAMP interacts with a cAMP-binding protein, different from PKA that mediates the stimulation of H,K-ATPase activity. Interestingly, this cAMP-binding protein is equally well activated by cAMP and by its analogue (R_p)-cAMPs conversely to PKA regulatory subunit, which is inhibited by (R_p)-cAMPs.

Lack of Implication of Cyclic Nucleotide-gated Channels in Sct-induced Stimulation of H,K-ATPase-- Because cyclic nucleotide-gated channels 3 are expressed at a high level in the kidney (15) and because Sct increases [Ca²⁺]_i in rat CCD (5), cyclic nucleotide-gated channels and [Ca²⁺]_i might possibly mediate the stimulation of H,K-ATPase activity. However, Sct-induced increase in [Ca²⁺]_i was markedly reduced by pretreating CCDs with 1 µM PKA-specific inhibitor H89 (Fig. 3). This finding demonstrates that these increases in [Ca²⁺]_i resulted from the activation of the canonical cAMP/PKA cascade. This conclusion is corroborated by the lack of stimulation of phospholipase C by calcitonin in CCDs (data not shown).

View larger version (16K): [in this window] [in a new window]   Fig. 3.   Calcitonin-induced changes in [Ca2+]i are dependent on PKA activation. CCDs were preincubated at 30 °C for 45 min in microdissection medium containing Fura-2/AM (10 µM) without or with the protein kinase A inhibitor H89 (1 µM). Afterward, samples were superfused at 37 °C without or with H89 with a solution containing 1 mM Ca2+ (instead of 0.5 mM for H,K-ATPase measurements) to amplify the magnitude of Ca2+ signals secondary to Ca2+ entry. After a 10-min equilibration period necessary to reach a stable [Ca2+]i level, tubules were stimulated successively with Sct (10 nM) and ATP (100 µM), a nucleotide known to stimulate phospholipase C in this segment through extracellular P2Y receptors (25). A and B, representative traces obtained in the same rat from a control and a H89-treated tubule respectively. C, mean [Ca2+]i increases (peak minus basal) calculated for each agonist from seven controls (solid bars) and seven H89-treated tubules (open bars) isolated from four rats. *, p < 0.001 versus control (no H89) by unpaired Student's t test.

These findings rule out a contribution of cyclic nucleotide-gated channels and increased [Ca²⁺]_i in the mediation of Sct on H,K-ATPase activity. They also demonstrate the presence of a functional H89-sensitive cAMP/PKA signaling pathway in I cells.

Role of Epac I in Sct-induced Stimulation of H,K-ATPase-- Epac I (also called cAMP-GEF I) is a guanine-nucleotide exchange factor specific of the monomeric G protein Rap-1, which is directly activated by cAMP (12, 13). Because Epac I is expressed at high levels in kidneys (12, 13), we evaluated whether it might be the target of cAMP involved in the stimulation of H,K-ATPase by Sct in I cells. For this purpose, we determined (a) whether Epac I and its target Rap-1 are expressed in rat collecting duct and (b) the role of Epac I in Sct-induced stimulation of H,K-ATPase.

Reverse transcription-PCR on microdissected nephron segments revealed that mRNAs encoding Epac I (Fig. 4A) and Rap-1 (Fig. 4B) were expressed along the whole nephron. However, the highest levels of expression were found in CCDs, which is compatible with a possible involvement of Epac I and Rap-1 in Sct action in CCD I cells. Indeed, the pretreatment of CCDs with polyclonal antibodies directed against either the C terminus (Fig. 5A) or the N terminus of Epac I (Fig. 5B) abolished Sct-induced stimulation of H,K-ATPase activity, whereas they did not alter the effect of Iso. Altogether, these results identify Epac I as the cAMP-binding protein involved in the stimulatory effect of calcitonin in CCD I cells.

View larger version (35K): [in this window] [in a new window]   Fig. 4.   Expression of Epac I and Rap-1 mRNAs along the nephron. mRNAs from one glomerulus or 1 mm of different segments of the nephron were reverse-transcribed, and the cDNA was amplified by PCR using primers specific for either Epac I (A) or Rap-1 (B). The DNA fragments were separated on 2% agarose gels and visualized using a PhosphorImager. The upper panels show representative gels from structures microdissected from a same animal. In each experiment, values were expressed as the percent of the PCT value, and the bottom panels show the means ± S.D. from four animals (with the exception of ATL for which n = 3). G, glomerulus; PCT, proximal convoluted tubule; PST, proximal straight tubule; TDL, thin descending limbs of Henle's loop; ATL, ascending limbs of Henle's loop; MTAL, medullary thick ascending limbs of Henle's loop; CTAL, cortical thick ascending limbs of Henle's loop; CCD, cortical duct; OMCD, outer medullary duct; and IMCD, inner medullary collecting duct.

View larger version (27K): [in this window] [in a new window]   Fig. 5.   Role of Epac I and Rap-1 on hormone-induced stimulation of H,K-ATPase. CCDs were transiently permeabilized with streptolysin-O (0.4 units ml1 for 8 min at 37 °C) in the absence (Control) or the presence of two antibodies (dilution 1:100) directed against the C terminus (A) or the N terminus of Epac I (B) and incubated at 4 °C for 90 min. Afterward, samples were incubated at 37 °C for 10 min without hormone (solid bars) or with either 10 nM salmon calcitonin (open bars) or 1 µM isoproterenol (hatched bars) before measuring H,K-ATPase activity. N, number of experiments. Statistical comparison between groups was performed by ANOVA with PLSD Fisher. *, p < 0.05; **, p < 0.005; and ***, p < 0.001 versus control groups (no hormone).

Signaling Pathway of Epac I in Sct-induced Stimulation of H,K-ATPase-- Because Rap-1 activates B-Raf that in turn controls the ERK1/2 pathway (26), we evaluated (a) the roles of Rap-1 and B-Raf in Sct-induced stimulation of H,K-ATPase, (b) whether Sct activates ERK1/2 in CCDs, and (c) whether activation of ERK1/2 mediates the stimulation of H,K-ATPase.

The pretreatment of CCDs with a polyclonal antibody directed against an epitope close to the C terminus of Rap-1 curtailed the stimulatory effect of Sct (Fig. 6A). In contrast, the pretreatment with a monoclonal antibody that inhibits the activity of the related G protein Ras did not alter the effect of Sct on H,K-ATPase activity (Fig. 6B). Similarly, the pretreatment with an antibody directed against the C terminus of B-Raf abolished the stimulatory effect of Sct on H,K-ATPase, whereas a monoclonal antibody mapping a C terminus epitope of the related kinase Raf-1 had no effect (Fig. 6, C and D).

View larger version (22K): [in this window] [in a new window]   Fig. 6.   Role of Rap-1 and B-Raf on hormone-induced stimulation of H,K-ATPase. CCDs were transiently permeabilized with streptolysin-O (0.4 units ml1 for 8 min at 37 °C) in the absence (Control) or the presence of two antibodies (dilution 1:100) directed against Rap-1 (A), related G protein Ras (B), B-Raf (C), or the kinase Ras (D). Afterward, samples were incubated at 37 °C for 10 min without hormone (solid bars) or with 10 nM salmon calcitonin (open bars) before measuring H,K-ATPase activity. N, number of experiments. Statistical comparison between groups was performed by ANOVA with PLSD Fisher. *, p < 0.05; **, p < 0.005; and ***, p < 0.001 versus control groups (no Sct).

Western blot analysis using an antibody against phospho-ERKs p42 and p44 demonstrates that calcitonin increased the phosphorylation of ERK1/2 by >50% and that this effect was insensitive to the PKA inhibitor H89 (Fig. 7A). (R_p)-cAMPs mimicked the effect of calcitonin on ERK1/2 phosphorylation (Fig. 7B). These findings are compatible with the involvement of ERK activation in the stimulation of H,K-ATPase by Sct. Indeed, the preincubation with 5 µM U0126, an inhibitor of the ERK kinase MEK (27), abolished Sct-induced stimulation of H,K-ATPase (Fig. 7C).

View larger version (30K): [in this window] [in a new window]   Fig. 7.   Calcitonin-induced phosphorylation of ERK1/2: Role in activation of H,K-ATPase. A and B, phosphorylation of ERK. After preincubation at 30 °C for 1 h in the absence (Control) or presence of 1 µM H89 (H89), rat CCDs were incubated at 37 °C for 10 min without (solid bars) or with either 10 nM salmon calcitonin (A, open bars) or 20 µM (Rp)-cAMPs (B, hatched bars). Afterward, samples were solubilized in Triton X-100, and phospho-ERK1/2 (p42 and p44) were revealed by Western blotting using a specific anti-phospho-ERK antibody. The upper panels show representative gels from a same animal. In each experiment, the densitometry of each lane (p42 plus p44) was expressed as the percent of the control value (absence of H89 and of hormone), and the bottom panels show the results of the mean ± S.D. from a number of animals. Statistical comparison between groups was performed by ANOVA with PLSD Fisher. *, p < 0.05 versus control values. C, role of ERK1/2 on Sct-induced stimulation of H,K-ATPase. After preincubation at 30 °C for 45 min without (bar C) or with 5 µM U0126, CCDs were incubated at 37 °C for 10 min without (solid bars) or with 10 nM salmon calcitonin (open bars). Afterward, H,K-ATPase activity was determined. N, numbers of experiments. Statistical comparison between groups was performed by ANOVA with PLSD Fisher. **, p < 0.001 versus control values (no Sct).

	DISCUSSION

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

This study shows that calcitonin-induced stimulation of H,K-ATPase in I cells of rat collecting duct is mediated by cAMP but is independent of PKA. Instead, it involves Epac I, the guanine-nucleotide exchange factor of the monomeric G protein Rap-1, whose activation triggers B-Raf and the MAPK kinase ERKs.

Study of Signaling Pathways in Native Cells-- A myriad of molecules participates in the intracellular control of cell functions. These molecules can constitute different signaling networks according to their level of expression, the presence of their various isoforms and their subcellular compartmentalization. Thus, the signaling pathways characterized in cultured and/or transfected cells may not be relevant in native cells under physiological conditions, especially in highly differentiated cells such as kidney epithelial cells. However, deciphering signaling pathways in native cells remains difficult because we lack specific pharmacological inhibitors for most intracellular signaling molecules.

In this study, we tentatively used antibodies directed against signaling proteins as specific inhibitors based on the hypothesis that the binding of an immunoglobulin on or close to the active site of a protein should alter its activity and/or its interaction with other proteins located upstream or downstream the signalization cascade. Although an inhibitory activity was previously demonstrated only for the anti-Ras antibody (22), the five antibodies, which were tested in this study, proved to display a biological effect. Furthermore, the inhibitory effect of an antibody may be as potent as that of a pharmacological inhibitor as illustrated in Fig. 1 for the anti PKA antibody. In addition, the biological effects of the antibodies were specific. (a) As shown on Fig. 1C, the anti-PKA antibody inhibited the effect of isoproterenol in I cells but not that of calcitonin in I cells, whereas two different anti Epac I antibodies curtailed calcitonin but not isoproterenol action (Fig. 5). (b) Antibodies directed against Rap-1 and B-Raf abolished calcitonin action, whereas antibodies directed against Ras and Raf-1, two related proteins of the same families, had no effect (Fig. 6).

Finally, transient permeabilization of cell membranes with streptolysin-O is a convenient method for integrating macromolecules into native epithelial cells, because it allows to maintain a cell integrity sufficient to preserve the activity of H,K-ATPase as well as its stimulation by hormones (see control activities in Figs. 1C, 5, and 6). This method could be useful to integrate recombinant proteins with constitutive activating or inhibiting mutations (positive or negative dominants).

Regulation of H,K-ATPase by Calcitonin and Isoproterenol in Rat CCD-intercalated Cells-- Although calcitonin and isoproterenol receptors can couple to effectors other than adenylyl cyclase (28-30), cAMP is responsible for the stimulation of H,K-ATPase in both I and I cells. Indeed, cAMP analogues or forskolin mimicked the hormone effects (Fig. 2, B and C), and inhibition of adenylyl cyclase prevented them (Fig. 2A). In I cells, cAMP effect on H,K-ATPase activity is mediated by PKA (Fig. 1) by a mechanism that has not been investigated. In contrast, in I cells, the blockade of PKA did not alter calcitonin-induced stimulation of H,K-ATPase (Fig. 1) despite the presence of a functional enzyme attested by its involvement in Sct-induced rise in [Ca²⁺]_i (Fig. 3). Instead, the stimulatory effect of cAMP on H,K-ATPase activity in I cells is mediated through its binding to Epac I (Fig. 5). Data from the literature indicate that the binding of cAMP to Epac I stimulates its guanine-nucleotide exchange activity and thereby activates the monomeric G protein Rap-1 (12, 13). Activated Rap-1 stimulates the kinase activity of B-Raf and the phosphorylation of the MAPK kinase MEK (26, 31), which in turn phosphorylates and activates ERK. The results from this study demonstrate the key roles of Rap-1, B-Raf, and ERK (Figs. 6 and 7) in the signalization of calcitonin action on H,K-ATPase in I cells (summarized in Fig. 8).

View larger version (14K): [in this window] [in a new window]   Fig. 8.   Schematic pathway underlying the stimulation of H,K-ATPase activity by calcitonin in -intercalated cells.

The involvement of ERKs in the regulation of H,K-ATPase activity in rat CCD I cells is demonstrated by the following. (a) Calcitonin increased the phosphorylation of ERKs (Fig. 7A). (b) The regulation of ERK and H,K-ATPase by calcitonin were both independent of PKA (Figs. 1 and 7A). (c) The inhibition of the ERK kinase MEK abolished the stimulatory effects of calcitonin on H,K-ATPase (Fig. 7C).

Because PKA was shown to stimulate ERK through direct activation of either Rap-1 (32) or B-Raf (31), the Epac I- and PKA-dependent mechanisms of ERK activation could coexist in the same cell. However, the finding that the anti-Epac I antibodies fully inhibited the effect of calcitonin on H,K-ATPase (Fig. 5) shows that PKA is not able to activate Rap-1 or B-Raf in I cells. This result suggests that the PKA pathway and the Epac I/Rap-1/B-Raf pathway are segregated into distinct subcellular compartments in CCD I cells.

In this study, the mechanism of H,K-ATPase activation beyond ERK has not been investigated. In most cells, the activation of ERK triggers its translocation into the nucleus where it activates transcription factors through direct phosphorylation (Elk-1, Myc, cAMP-response element-binding protein, Sap-1) or through phosphorylation of kinases such as p90RSK. In turn, these activated transcription factors control the expression of specific genes. The rapid time course of calcitonin-induced activation of H,K-ATPase activity (<10 min) rules out a possible mediation through de novo synthesis of its subunits and suggests an activation of preexisting ATPase units. Several observations support that calcitonin may stimulate H,K-ATPase activity through exocytotic insertion into the plasma membrane of H,K-ATPase units present in the membrane of cytoplasmic vesicles. (a) H,K-ATPase colocalizes with H-ATPase (33), an other proton pump that is controlled through exocytosis/endocytosis in CCD I cells (34). (b) In gastric mucosa, functional expression of H,K-ATPase at the luminal membrane of parietal cells is achieved through exocytosis (35). (c) ERKs control exocytosis in several cell types (36-38).

In conclusion, this study provides original data regarding several aspects of protein G-coupled receptor signalization in native kidney cells. (a) It outlines the important role of Epac I in mediating some effects of cAMP in collecting duct cells. (b) It demonstrates an intracellular compartmentalization of cAMP effects. (c) It indicates that ion transporters such as H,K-ATPase can be extranuclear effectors of ERK signalization. The expression of Epac I in other nephron segments (Fig. 4A) suggests that many other effects of cAMP-producing hormones, usually attributed to the activation of PKA, may be mediated in fact through the activation of Epac I and ERKs.

	ACKNOWLEDGEMENTS

We thank Drs. J. L. Bos and J. de Rooij for helpful discussions and suggestions.

	FOOTNOTES

^* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: URA 1859, Bâtiment 520, Centre d'Etudes de Saclay, 91191 Gif-sur-Yvette cedex, France. Tel.: 33-169089761; Fax: 33-169083570; E-mail: doucet@dsvidf.cea.fr.

Published, JBC Papers in Press, March 15, 2002, DOI 10.1074/jbc.M201868200

	ABBREVIATIONS

The abbreviations used are: CCD, cortical collecting duct; 8-Br-cAMP, 8-bromo-cyclic AMP; ERK, extracellular signal-regulated kinase; MAPK, mitogen-activated protein kinase; Pipes, 1,4-piperazinediethanesulfonic acid; ANOVA, analysis of variance; PLSD, protected least significant difference test; MEK, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase; Iso, isoproterenol; I cell, -intercalated cell; I cell, -intercalated cell; PKA, protein kinase A; Sct, salmon calcitonin; GEF, guanine-nucleotide exchange factor.

	REFERENCES

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				Y. Li, I. B. M. Konings, J. Zhao, L. S. Price, E. de Heer, and P. M. T. Deen Renal expression of exchange protein directly activated by cAMP (Epac) 1 and 2 Am J Physiol Renal Physiol, August 1, 2008; 295(2): F525 - F533. [Abstract] [Full Text] [PDF]

				T. R. H. Buch, H. Biebermann, H. Kalwa, O. Pinkenburg, D. Hager, H. Barth, K. Aktories, A. Breit, and T. Gudermann G13-dependent Activation of MAPK by Thyrotropin J. Biol. Chem., July 18, 2008; 283(29): 20330 - 20341. [Abstract] [Full Text] [PDF]

				A. H. Eid, M. A. Chotani, S. Mitra, T. J. Miller, and N. A. Flavahan Cyclic AMP acts through Rap1 and JNK signaling to increase expression of cutaneous smooth muscle {alpha}2C-adrenoceptors Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H266 - H272. [Abstract] [Full Text] [PDF]

				S. Granholm, P. Lundberg, and U. H Lerner Calcitonin inhibits osteoclast formation in mouse haematopoetic cells independently of transcriptional regulation by receptor activator of NF-{kappa}B and c-Fms J. Endocrinol., December 1, 2007; 195(3): 415 - 427. [Abstract] [Full Text] [PDF]

				M. Ishida, T. Mitsui, K. Yamakawa, N. Sugiyama, W. Takahashi, H. Shimura, T. Endo, T. Kobayashi, and J. Arita Involvement of cAMP response element-binding protein in the regulation of cell proliferation and the prolactin promoter of lactotrophs in primary culture Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1529 - E1537. [Abstract] [Full Text] [PDF]

				S. Dremier, M. Milenkovic, S. Blancquaert, J. E. Dumont, S. O. Doskeland, C. Maenhaut, and P. P. Roger Cyclic Adenosine 3',5'-Monophosphate (cAMP)-Dependent Protein Kinases, But Not Exchange Proteins Directly Activated by cAMP (Epac), Mediate Thyrotropin/cAMP-Dependent Regulation of Thyroid Cells Endocrinology, October 1, 2007; 148(10): 4612 - 4622. [Abstract] [Full Text] [PDF]

				D. Chen, S. Reierstad, Z. Lin, M. Lu, C. Brooks, N. Li, J. Innes, and S. E. Bulun Prostaglandin E2 Induces Breast Cancer Related Aromatase Promoters via Activation of p38 and c-Jun NH2-Terminal Kinase in Adipose Fibroblasts Cancer Res., September 15, 2007; 67(18): 8914 - 8922. [Abstract] [Full Text] [PDF]